Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Number of holders
-
36
-
Total 13F principal, excl. options
-
388,171,404
-
Principal change
-
+15,667,454
-
Total reported value, excl. options
-
$395,200,546
-
Value change
-
+$22,297,025
-
Number of buys
-
17
-
Number of sells
-
20
-
Price
-
$1.01
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q2 2018
As of 30 Jun 2018 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 36 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $388,171,404 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, OAKTREE CAPITAL MANAGEMENT LP, ZAZOVE ASSOCIATES LLC, STATE STREET CORP, SHENKMAN CAPITAL MANAGEMENT INC, Man Group plc, BAKER BROS. ADVISORS LP, and PUTNAM INVESTMENTS LLC.
This table shows 36 bond principal holders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.